Johnson & Johnson [JNJ] stock is trading at $195.25, up 0.44%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The JNJ shares have gain 4.43% over the last week, with a monthly amount glided 2.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Johnson & Johnson [NYSE: JNJ] stock has seen the most recent analyst activity on November 13, 2025, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $230. Previously, Daiwa Securities upgraded its rating to Outperform on October 20, 2025, and kept the price target unchanged to $203. On October 03, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $212 on the stock. Guggenheim upgraded its rating to a Buy but stick to its price target of $206 on September 23, 2025. Erste Group upgraded its rating to a Buy. Leerink Partners downgraded its rating to Market Perform for this stock on May 13, 2025, but kept the price target unchanged to $153.
Johnson & Johnson [JNJ] stock has fluctuated between $140.68 and $195.54 over the past year. Currently, Wall Street analysts expect the stock to reach $200.7 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $195.25 at the most recent close of the market. An investor can expect a potential return of 2.79% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
Johnson & Johnson [NYSE:JNJ] reported sales of 92.15B for the trailing twelve months, which represents a growth of 6.77%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.34%, and Net Profit Margin reading is 0.27%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.33 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 193.80 points at the first support level, and at 192.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 196.35, and for the 2nd resistance point, it is at 197.45.
Ratios To Look Out For
For context, Johnson & Johnson’s Current Ratio is 1.07. Further, the Quick Ratio stands at 0.80, while the Cash Ratio is 0.36. Considering the valuation of this stock, the price to sales ratio is 5.11, the price to book ratio is 5.93 and price to earnings (TTM) ratio is 18.84.
Transactions by insiders
Recent insider trading involved JOHNSON & JOHNSON, 10% Owner, that happened on Nov 06 ’25 when 52332.0 shares were sold. 10% Owner, JOHNSON & JOHNSON completed a deal on Nov 07 ’25 to sell 200.0 shares. Meanwhile, EVP, Innovative Medicine, R&D REED JOHN C sold 21721.0 shares on Oct 17 ’25.
